These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25591983)

  • 1. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
    Kumar M; Srivastava G; Kaur J; Assi J; Alyass A; Leong I; MacMillan C; Witterick I; Shukla NK; Thakar A; Duggal R; Roychoudhury A; Sharma MC; Walfish PG; Chauhan SS; Ralhan R
    J Transl Med; 2015 Jan; 13():8. PubMed ID: 25591983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
    Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
    Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
    Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
    Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
    Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A2, a potential marker for early recurrence in early-stage oral cancer.
    Tsai ST; Jin YT; Tsai WC; Wang ST; Lin YC; Chang MT; Wu LW
    Oral Oncol; 2005 Apr; 41(4):349-57. PubMed ID: 15792606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.
    Kyriazanos ID; Tachibana M; Dhar DK; Shibakita M; Ono T; Kohno H; Nagasue N
    Oncol Rep; 2002; 9(3):503-10. PubMed ID: 11956617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
    Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
    Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
    BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.
    Masuda T; Ishikawa T; Mogushi K; Okazaki S; Ishiguro M; Iida S; Mizushima H; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2016 Mar; 48(3):975-82. PubMed ID: 26783118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer.
    Kwon M; Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY; Lee BH
    Eur J Cancer; 2015 Jan; 51(2):177-85. PubMed ID: 25483786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
    Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma.
    Imazawa M; Hibi K; Fujitake S; Kodera Y; Ito K; Akiyama S; Nakao A
    Anticancer Res; 2005; 25(2B):1247-50. PubMed ID: 15865073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
    Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
    Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.